Crestwood Advisors Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Buy
25,536
+8,364
+49% +$55.7K ﹤0.01% 811
2026
Q1
$93.6K Buy
+17,172
New +$96.3K ﹤0.01% 758
2022
Q1
Sell
-2,605
Closed -$239K 309
2021
Q4
$239K Sell
2,605
-500
-16% -$59.8K 0.01% 271
2021
Q3
$394K Sell
3,105
-1,620
-34% -$236K 0.01% 211
2021
Q2
$786K Sell
4,725
-1,158
-20% -$188K 0.02% 169
2021
Q1
$1.07M Sell
5,883
-232
-4% -$53.8K 0.03% 147
2020
Q4
$1.22M Buy
6,115
+3,718
+155% +$756K 0.04% 136
2020
Q3
$526K Buy
2,397
+375
+19% +$79.4K 0.02% 166
2020
Q2
$386K Buy
2,022
+645
+47% +$113K 0.02% 179
2020
Q1
$213K Buy
+1,377
New +$160K 0.01% 203

Other funds holding TDOC

Crestwood Advisors Group's TDOC Position: Q2 2026 in Review

Crestwood Advisors Group increased its Teladoc Health (TDOC) stake by 49% in Q2 2026, buying an estimated $55.7K and bringing the position to 25,536 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Crestwood Advisors Group first reported a position in TDOC in Q1 2020 and has held it in 10 quarters since. The position peaked at $1.22M in Q4 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Crestwood Advisors Group held 25,536 shares of Teladoc Health worth $217K as of Q2 2026.
  • Crestwood Advisors Group bought 8,364 Teladoc Health shares in Q2 2026, an estimated $55.7K.
  • Teladoc Health made up ﹤0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #811 holding.
  • Crestwood Advisors Group first reported a position in Teladoc Health in Q1 2020 and has held it in 10 quarters since.
  • Crestwood Advisors Group's Teladoc Health position peaked at $1.22M in Q4 2020.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.